Thermo Fisher Scientific, Inc. (TMO)
699.92
+0.48
(+0.07%)
USD |
NYSE |
Nov 13, 16:00
696.53
-3.39
(-0.48%)
After-Hours: 19:59
Thermo Fisher Scientific Enterprise Value : 294.59B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 294.59B |
| November 11, 2026 | 301.36B |
| November 10, 2026 | 301.54B |
| November 09, 2026 | 302.81B |
| November 06, 2026 | 292.85B |
| November 05, 2026 | 286.25B |
| November 04, 2026 | 297.08B |
| November 03, 2026 | 294.18B |
| November 02, 2026 | 288.37B |
| October 30, 2026 | 293.68B |
| October 29, 2026 | 298.20B |
| October 28, 2026 | 296.33B |
| October 27, 2026 | 292.21B |
| October 26, 2026 | 289.20B |
| October 23, 2026 | 285.09B |
| October 22, 2026 | 286.10B |
| October 21, 2026 | 292.58B |
| October 20, 2026 | 290.11B |
| October 19, 2026 | 287.15B |
| October 16, 2026 | 291.09B |
| October 15, 2026 | 293.49B |
| October 14, 2026 | 284.86B |
| October 13, 2026 | 281.10B |
| October 12, 2026 | 280.80B |
| October 09, 2026 | 279.24B |
| Date | Value |
|---|---|
| October 08, 2026 | 277.00B |
| October 07, 2026 | 280.74B |
| October 06, 2026 | 278.71B |
| October 05, 2026 | 286.18B |
| October 02, 2026 | 278.05B |
| October 01, 2026 | 277.20B |
| September 30, 2026 | 285.55B |
| September 29, 2026 | 289.89B |
| September 28, 2026 | 289.51B |
| September 25, 2026 | 288.18B |
| September 24, 2026 | 289.43B |
| September 23, 2026 | 284.59B |
| September 22, 2026 | 282.09B |
| September 21, 2026 | 282.18B |
| September 18, 2026 | 279.47B |
| September 17, 2026 | 282.01B |
| September 16, 2026 | 278.36B |
| September 15, 2026 | 275.75B |
| September 14, 2026 | 265.49B |
| September 11, 2026 | 264.08B |
| September 10, 2026 | 261.63B |
| September 09, 2026 | 262.55B |
| September 08, 2026 | 261.57B |
| September 04, 2026 | 265.55B |
| September 03, 2026 | 267.26B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.97B |
| Bio-Rad Laboratories, Inc. | 9.660B |
| Danaher Corp. | 185.41B |
| Illumina, Inc. | 32.83B |
| Revvity, Inc. | 19.70B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.727B |
| Revenue (Quarterly) | 12.14B |
| Total Expenses (Quarterly) | 10.42B |
| EPS Diluted (Quarterly) | 4.639 |
| Gross Profit Margin (Quarterly) | 42.34% |
| Profit Margin (Quarterly) | 14.23% |
| Earnings Yield | 2.71% |
| Operating Earnings Yield | 3.47% |
| Normalized Earnings Yield | 2.756 |